PDCD1 and neoplasm: The combination of PD-1 blockade and RT was significantly more effective than either modality alone (p < 0.05 by log-rank Mantle–Cox), with 15 to 40% of mice treated with the combination achieving long-term survival (>90 days after tumor implantation) [16].